Rafael A. De La Barrera

Walter Reed Army Institute of Research — United States

Medicine · Health Sciences

14h-index2.1kcitations25works10.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(23), Viral Infections and Vectors(21), Virology and Viral Diseases(14), Malaria Research and Control(3), Viral Infections and Outbreaks Research(3)

Publications25 total

Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection
npj Vaccines·2024· 4 citedOpen Access
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial
The Lancet Infectious Diseases·2024· 18 cited
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
npj Vaccines·2024· 12 citedOpen Access
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice
npj Vaccines·2024· 9 citedOpen Access
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
Cell Reports·2023· 15 citedOpen Access
Author Correction: Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets
npj Vaccines·2022· 3 citedOpen Access
Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice
Microorganisms·2022· 8 citedOpen Access
Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets
npj Vaccines·2022· 22 citedOpen Access
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice
PLoS Pathogens·2021· 9 citedOpen Access
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
Frontiers in Immunology·2021· 19 citedOpen Access
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
Annals of Internal Medicine·2021· 76 cited
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
The Lancet Infectious Diseases·2020· 55 citedOpen Access
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
Nature Medicine·2020· 85 citedOpen Access
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1
mSphere·2020· 13 citedOpen Access
Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR−/− Mice
Cell Host & Microbe·2019· 32 citedOpen Access
Immunological Assays used to Support Efficacy of Zika Virus Vaccines
Tropical Medicine and Infectious Disease·2019· 3 citedOpen Access
Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys
Cell·2018· 129 citedOpen Access
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Science Translational Medicine·2017· 123 citedOpen Access
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
The Lancet·2017· 193 citedOpen Access
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys
Cell·2017· 209 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Stephen J. Thomas(13), Dan H. Barouch(13), Kayvon Modjarrad(13), Peter Abbink(12), Rafael A. Larocca(11), Kenneth H. Eckels(11), Richard G. Jarman(10), Erica N. Borducchi(9), Nelson L. Michael(9), Michael Boyd(5), Abishek Chandrashekar(5), Kathryn E. Stephenson(5), Gregory D. Gromowski(5), Marinela Kirilova(4), Ramya Nityanandam(4), Noe B. Mercado(4), Edward T. Moseley(4), David Jetton(4), Mark G. Lewis(4), Amanda J. Martinot(4)